Bangkok Lab And Cosmetic Public Company Limited (SET: BLC)
Health Care · Pharmaceuticals · TH
฿3.96
+0.51% today · -3.9% 1Y
Bangkok Lab And Cosmetic Public Company Limited (SET: BLC) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $70.81M.
Over the last twelve months the share price has lost 3.9%, trading between 3.64 and 4.36.
Tweenvest scores Bangkok Lab And Cosmetic Public Company Limited across four factors: quality 77/100, value 49/100, growth 56/100, dividend 92/100. Its strongest factor is dividend.
BLC price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $70.81M
- Revenue (TTM)
- $49.37M
- P/E
- 15.40
- EPS
- 0.26
- Dividend yield
- 6.31%
- Beta (5Y)
- 0.32
- 52-week high
- ฿4.36
- 52-week low
- ฿3.64
- Avg volume (3M)
- —
- Shares outstanding
- 600.00M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| PhytoHealth CorporationTWSE: 4108 | $71.75M | NT$11.55 | +1.76% |
| Domesco Medical Import - Export Joint-Stock CorporationHOSE: DMC | $71.51M | ₫53,300.00 | -2.74% |
| Cingulate Inc.NasdaqCM: CING | $71.11M | $4.85 | -0.82% |
| Cantourage Group SEXTRA: HIGH | $70.93M | €4.98 | -1.97% |
| Wanbury LimitedBSE: 524212 | $70.71M | Rs195.85 | -1.58% |
| DongKoo Bio & Pharma Co., Ltd.KOSDAQ: A006620 | $70.70M | ₩3,515.00 | -0.14% |
| Verrica Pharmaceuticals Inc.NasdaqCM: VRCA | $70.60M | $4.08 | -0.73% |
| Poolbeg Pharma PLCAIM: POLB | $69.71M | £0.07 | -3.90% |
Figures last refreshed Oct 11, 2026.